Vamotinib (PF-114) is an orally active and specific tyrosine kinase inhibitor with antiproliferative and antitumour activity.Vamotinib inhibits the phosphorylation of BCR/ABL and BCR/ABL-T315I, which promotes apoptosis. Vamotinib is used to study drug-resistant Philadelphia chromosome-positive (Ph+) leukaemia and Alzheimers disease.
Molekulargewicht:
532.56
Reinheit:
99.64%
CAS Nummer:
[1416241-23-0]
Formel:
C29H27F3N6O
Target-Kategorie:
Bcr-Abl|||Tyrosine Kinases|||Apoptosis
T63746
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten